Materials & Packaging

Request for TOC Request for Sample
BUY NOW

North America Pharmaceutical Vials Market - Industry Trends and Forecast to 2028

Materials & Packaging | Published Report | Feb 2021 | North America | 350 Pages | No of Tables: 140 | No of Figures: 35

Report Description

North America Pharmaceutical Vials Market, By Material (Glass, Plastic and Others), Neck Type (Screw Neck, Crimp Neck, Double Chamber, Flip Cap and Others), Cap Size (13-425 mm, 15-425 mm, 18-400 mm, 22-350 mm, 24-400 mm, 8-425 mm, 9mm and Others), Distribution Channel (Direct Sales, Medical Stores/Pharmacies, E-Commerce and Others), Capacity (1 ml,2 ml, 3 ml, 4 ml, 8 ml, 10 ml, 20 ml, 30 ml, 50 ml and Others), Drug Type (Injectable and Non-Injectable), Application (Oral, Nasal, Injectable and Others), End-User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Development and Manufacturing Companies, Compound Pharmacy and Others), Market (Parenteral, Gastro, ENT and Others), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2028


Market Analysis and Insights: North America Pharmaceutical Vials Market

Pharmaceutical vials market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 6.9% in the forecast period of 2021 to 2028 and expected to reach USD 9,007.39 million by 2028.

Pharmaceutical vials is the kind of small plastic or glass or plastic vessel which are used in the storage of medication which are used mainly in the storage of liquid and sometimes for liquid, capsules form. The pharmaceutical vials are present in various areas such as pharmaceutical companies, biopharmaceutical companies, and compound pharmacy and in several other places. The pharmaceutical vials are manufactured by the usage of various materials such as plastic, glass and from various others. Vials helps in providing the shelf life as well as durability to the products.

Several manufactures are engaged in the production of the high quality packing products form glass and plastic material which can help to increase the shelf life of the pharmaceutical products. The multilayer design packaging products in the pharmaceutical industry offers additional integrity assurance, even under force impact. For the packaging of the toxic or high potency drug solutions the demand of the combined crack resistance and integrity performance packaging products is increasing in pharmaceutical industry.

This Pharmaceutical vials market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.


North America Pharmaceutical Vials Market Scope and Market Size

North America pharmaceutical vials market is segmented of the basis into material, neck type, cap size, distribution channel, capacity, drug type, application, end-user and market. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of material, the pharmaceutical vials market is segmented into plastic, glass and others. In 2021, glass is dominating because of the non-leakage properties which are driving pharmaceutical vials market.
  • On the basis of neck type, the pharmaceutical vials market is segmented into crimp neck, double chamber, screw neck, flip cap and others. In 2021, Screw neck segment is dominating because of growing application in gastro sector.
  • On the basis of cap size, the market is segmented into 13-425 MM, 15-425 MM, 18-400 MM, 22-350 MM, 24-400 MM, 8-425 MM, 9MM and others. In 2021, 9MM is dominating because the processing takes place at large scale due to requirement.
  • On the basis of distribution channel, the market is segmented into direct sales, medical stores/pharmacies, e-commerce and others. In 2021, direct sales are dominating because of the huge build relationships with the customers which boost the demand of the pharmaceutical vials market.
  • On the basis of capacity, the market is segmented into 1 ML, 2 ML, 3 ML, 4 ML, 8 ML, 10 ML, 20 ML, 30 ML, 50 ML and others. In 2021, 1 ML is dominating because of high efficiency which boosts the demand of the pharmaceutical vials market.
  • On the basis of drug type, the market is segmented into injectable and non-injectable. In 2021, Injectable is dominating because of properties which control the dosage consumption amount that maximizes its application.
  • On the basis of application, the market is segmented into nasal, oral and others. In 2021, Oral is dominating because of the huge amount of consumption in biopharmaceutical companies.
  • On the basis of end-user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, contract development and manufacturing companies, compound pharmacy and others. In 2021, pharmaceutical companies are dominating because of increasing formation of medicines to treat various diseases that is the reason which boosts the demand of the pharmaceutical vials market.
  • On the basis of market, the pharmaceutical vials market is segmented into parenteral, gastro, ENT and others. In 2021, the parenteral segment is dominating because of the features that enhances medication adherence.

Pharmaceutical vials Market Country Level Analysis

North America pharmaceutical vials market is analysed and market size information is provided by material, neck type, cap size, distribution channel, capacity, drug type, application, end-user and market.

The countries covered in the pharmaceutical vials market report are U.S., Canada and Mexico in North America.

North America pharmaceutical vials market is dominating the market due to growing demand of packaging in pharmaceutical industry in the region. The U.S. is dominating in the pharmaceutical vials market as pharmaceutical vials products are highly manufactured and consumed in the country. Also, high innovations and development in the manufacturing of products is one of the major factors for the growth of the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growth in the Pharmaceutical Vials Industry

North America pharmaceutical vials market also provides you with detailed market analysis for every country growth in installed base of different kind of products for pharmaceutical vials market, impact of technology using life line curves and changes in infant formula regulatory scenarios and their impact on the pharmaceutical vials market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Pharmaceutical Vials Market Share Analysis

North America pharmaceutical vials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to North America pharmaceutical vials market.

The major players covered in the report are Gerresheimer AG, SCHOTT AG , Berry Global Inc., West Pharmaceutical Services Inc, Origin Pharma Packaging, SGD Pharma, Pacific Vial Manufacturing Inc., Bormioli Pharma S.p.a, TOYOBO CO., LTD., NIPRO, Piramal Glass Private Limited, Corning Incorporated, DWK Life Sciences Ltd, APG and Stevanato Group, among other players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

  • In May 2020, Piramal Glass Private Limited. company have decided make development in the business with transformation of the glass packaging products to a digital glass manufacturer. This development helps the company to increase revenue..


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL VIALS MARKET

1.4 LIMITATION

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 DRUG TYPE LIFE LINE CURVE

2.7 MULTIVARIATE MODELLING

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 DBMR MARKET CHALLENGE MATRIX

2.12 VENDOR SHARE ANALYSIS

2.13 IMPORT-EXPORT DATA

2.14 SECONDARY SOURCES

2.15 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 GROWING DEMAND OF PACKAGING IN PHARMACEUTICAL INDUSTRY

5.1.2 GROWING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING

5.1.3 GROWTH OF PREFILLED SYRINGES

5.1.4 GROWING HEALTH AWARENESS AND ADOPTION OF NEW TECHNIQUES FOR STORAGE OF LIQUID MEDICINE

5.2 RESTRAINTS

5.2.1 CHEMICALS RELEASE OF THE INTERNAL SURFACE OF GLASS TUBING CONTAINERS

5.2.2 INCREASING COST OF OVERALL PACKAGING

5.3 OPPORTUNITIES

5.3.1 IMPLEMENTING READY-TO USE GLASS VIALS FOR FLEXIBLE ASEPTIC FILLING

5.3.2 INCREASING DEMAND OF PACKAGING FOR COVID-19 VACCINE

5.4 CHALLENGES

5.4.1 RECYCLING OF WASTE PRODUCE BY PHARMACEUTICAL PACKAGING

5.4.2 INCREASING GOVERNMENT REGULATIONS TOWARDS PHARMACEUTICAL SECTOR

6 COVID-19 IMPACT ON THE PHARMACEUTICAL VIALS MARKET IN CHEMICAL AND MATERIALS INDUSTRY

6.1 ANALYSIS ON IMPACT OF COVID-19 ON THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET

6.2 AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVE TO BOOST THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET

6.3 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE

6.4 PRICE IMPACT

6.5 IMPACT ON DEMAND

6.6 IMPACT ON SUPPLY CHAIN

6.7 CONCLUSION

7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL

7.1 OVERVIEW

7.2 GLASS

7.2.1 GLASS BY COLOR

7.2.1.1 Amber

7.2.1.2 Clear

7.2.1.3 Others

7.2.2 GLASS BY TYPE

7.2.2.1 TYPE I (Borosilicate Glass)

7.2.2.2 TYPE II (Treated Soda-Lime Glass)

7.2.2.3 TYPE III (Regular Soda Lime Glass)

7.2.2.4 TYPE IV (Type Np Glass/General-Purpose Soda Lime Glass)

7.2.3 GLASS BY PRODUCT

7.2.3.1 Serum / Specialty Glass Vials

7.2.3.2 Screw Thread Glass Vials

7.2.3.3 Sterile Glass Vials

7.2.3.4 Sample Glass Vials

7.2.3.5 Autosampler Vials

7.2.3.6 Chromatography Vials

7.2.3.7 Epa Voa Vials

7.2.3.8 Others

7.3 PLASTIC

7.3.1 PLASTIC BY COLOR

7.3.1.1 Translucent

7.3.1.2 Opaque

7.3.1.3 Others

7.3.2 PLASTIC BY TYPE

7.3.2.1 High-density polyethylene (HDPE)

7.3.2.2 Polystyrene

7.3.2.3 Polypropylene

7.3.2.4 Polyvinyl Chloride (PVC)

7.3.2.5 Polycarbonate

7.3.2.6 Polyester

7.3.2.7 Others

7.4 OTHERS

8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE

8.1 OVERVIEW

8.2 SCREW NECK

8.3 CRIMP NECK

8.4 DOUBLE CHAMBER

8.5 FLIP CAP

8.6 OTHERS

9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE

9.1 OVERVIEW

9.2 9MM

9.3 8-425 MM

9.4 13-425 MM

9.5 15-425 MM

9.6 18-400 MM

9.7 22-350 MM

9.8 24-400 MM

9.9 OTHERS

10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT SALES

10.3 MEDICAL STORES/PHARMACIES

10.4 E-COMMERCE

10.5 OTHERS

11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY

11.1 OVERVIEW

11.2 1 ML

11.3 2 ML

11.4 3 ML

11.5 4 ML

11.6 8 ML

11.7 10 ML

11.8 20 ML

11.9 30 ML

11.1 50 ML

11.11 OTHERS

12 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE

12.1 OVERVIEW

12.2 INJECTABLE

12.2.1 INJECTABLE TYPE

12.2.1.1 Lyophilized

12.2.1.2 Liquid

12.3 NON-INJECTABLE

12.3.1 NON-INJECTABLE TYPE

12.3.1.1 Diagnostic

12.3.1.2 Solid

13 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION

13.1 OVERVIEW

13.2 ORAL

13.3 NASAL

13.4 OTHERS

14 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER

14.1 OVERVIEW

14.2 PHARMACEUTICAL COMPANIES

14.3 BIOPHARMACEUTICAL COMPANIES

14.4 CONTRACT DEVELOPMENT AND MANUFACTURING COMPANIES

14.5 COMPOUND PHARMACY

14.6 OTHERS

15 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET

15.1 OVERVIEW

15.2 PARENTERAL

15.3 GASTRO

15.4 ENT

15.5 OTHERS

16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY GEOGRAPHY

16.1 OVERVIEW

16.2 NORTH AMERICA

16.2.1 U.S.

16.2.2 CANADA

16.2.3 MEXICO

17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

17.2 MERGERS & ACQUISITIONS

17.3 EXPANSIONS

17.4 NEW PRODUCT DEVELOPMENT

18 SWOT ANALYSIS

19 COMPANY PROFILES

19.1 BERRY NORTH AMERICA INC.

19.1.1 COMPANY SNAPSHOT

19.1.2 REVENUE ANALYSIS

19.1.3 COMPANY SHARE ANALYSIS

19.1.4 PRODUCT PORTFOLIO

19.1.5 RECENT UPDATE

19.2 WEST PHARMACEUTICAL SERVICES, INC.

19.2.1 COMPANY SNAPSHOT

19.2.2 REVENUE ANALYSIS

19.2.3 COMPANY SHARE ANALYSIS

19.2.4 PRODUCT PORTFOLIO

19.2.5 RECENT UPDATE

19.3 PIRAMAL GLASS PRIVATE LIMITED (A SUBSIDIARY OF PIRAMAL ENTERPRISES LTD.)

19.3.1 COMPANY SNAPSHOT

19.3.2 REVENUE ANALYSIS

19.3.3 COMPANY SHARE ANALYSIS

19.3.4 PRODUCT PORTFOLIO

19.3.5 RECENT UPDATE

19.4 TOYOBO CO., LTD.

19.4.1 COMPANY SNAPSHOT

19.4.2 REVENUE ANALYSIS

19.4.3 COMPANY SHARE ANALYSIS

19.4.4 PRODUCT PORTFOLIO

19.4.5 RECENT UPDATE

19.5 CORNING INCORPORATED

19.5.1 COMPANY SNAPSHOT

19.5.2 REVENUE ANALYSIS

19.5.3 COMPANY SHARE ANALYSIS

19.5.4 PRODUCT PORTFOLIO

19.5.5 RECENT UPDATES

19.6 GERRESHEIMER AG

19.6.1 COMPANY SNAPSHOT

19.6.2 REVENUE ANALYSIS

19.6.3 PRODUCT PORTFOLIO

19.6.4 RECENT UPDATE

19.7 NIPRO

19.7.1 COMPANY SNAPSHOT

19.7.2 REVENUE ANALYSIS

19.7.3 PRODUCT PORTFOLIO

19.7.4 RECENT UPDATE

19.8 SCHOTT AG

19.8.1 COMPANY SNAPSHOT

19.8.2 PRODUCT PORTFOLIO

19.8.3 RECENT UPDATE

19.9 APG

19.9.1 COMPANY SNAPSHOT

19.9.2 PRODUCT PORTFOLIO

19.9.3 RECENT UPDATE

19.1 BORMIOLI PHARMA S.P.A.

19.10.1 COMPANY SNAPSHOT

19.10.2 PRODUCT PORTFOLIO

19.10.3 RECENT UPDATE

19.11 DWK LIFE SCIENCES LTD.

19.11.1 COMPANY SNAPSHOT

19.11.2 PRODUCT PORTFOLIO

19.11.3 RECENT UPDATE

19.12 ORIGIN PHARMA PACKAGING

19.12.1 COMPANY SNAPSHOT

19.12.2 PRODUCT PORTFOLIO

19.12.3 RECENT UPDATE

19.13 PACIFIC VIAL

19.13.1 COMPANY SNAPSHOT

19.13.2 PRODUCT PORTFOLIO

19.13.3 RECENT UPDATE

19.14 SGD PHARMA (A SUBSIDIARY OF SAINT-GOBAIN)

19.14.1 COMPANY SNAPSHOT

19.14.2 REVENUE ANALYSIS

19.14.3 PRODUCT PORTFOLIO

19.14.4 RECENT UPDATE

19.15 STEVANATO GROUP

19.15.1 COMPANY SNAPSHOT

19.15.2 PRODUCT PORTFOLIO

19.15.3 RECENT UPDATE

20 QUESTIONNAIRE

21 RELATED REPORTS

List of Table

LIST OF TABLES 

TABLE 1 IMPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)

TABLE 2 EXPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)

TABLE 3 TIME TAKEN FOR GARBAGE TO DECOMPOSE IN THE ENVIRONMENT (2015)

TABLE 4 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY TYPE, 2019-2028 (MILLION UNITS)

TABLE 6 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY REGION, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY REGION, 2019-2028 (MILLION UNITS)

TABLE 8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY REGION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY REGION, 2019-2028 (MILLION UNITS)

TABLE 13 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (MILLION UNITS)

TABLE 17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, SCREW NECK BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, CRIMP NECK BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, DOUBLE CHAMBER BY REGION, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, FLIP CAP BY REGION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 9MM BY REGION, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 8-425 MM BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 13-425 MM BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 15-425 MM BY REGION, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 18-400 MM BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 22-350 MM BY REGION, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 24-400 MM BY REGION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, DIRECT SALES BY REGION, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, MEDICAL STORES/PHARMACIES BY REGION, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, E-COMMERCE BY REGION, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 1 ML BY REGION, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 2 ML BY REGION, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 3 ML BY REGION, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 4 ML BY REGION, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 8 ML BY REGION, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 10 ML BY REGION, 2019-2028 (USD MILLION)

TABLE 44 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 20 ML BY REGION, 2019-2028 (USD MILLION)

TABLE 45 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 30 ML BY REGION, 2019-2028 (USD MILLION)

TABLE 46 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 50 ML BY REGION, 2019-2028 (USD MILLION)

TABLE 47 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, INJECTABLE BY REGION, 2019-2028 (USD MILLION)

TABLE 50 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY INJECTABLE TYPE, 2019-2028 (USD MILLION)

TABLE 51 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, NON-INJECTABLE BY REGION, 2019-2028 (USD MILLION)

TABLE 52 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NON-INJECTABLE TYPE, 2019-2028 (USD MILLION)

TABLE 53 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 54 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, ORAL BY REGION, 2019-2028 (USD MILLION)

TABLE 55 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, NASAL BY REGION, 2019-2028 (USD MILLION)

TABLE 56 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)

TABLE 57 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER, 2019-2028 (USD MILLION)

TABLE 58 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PHARMACEUTICAL COMPANIES BY REGION, 2019-2028 (USD MILLION)

TABLE 59 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BIOPHARMACEUTICAL COMPANIES BY REGION, 2019-2028 (USD MILLION)

TABLE 60 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, CONTRACT DEVELOPMENT AND MANUFACTURING COMPANIES BY REGION, 2019-2028 (USD MILLION)

TABLE 61 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, COMPOUND PHARMACY BY REGION, 2019-2028 (USD MILLION)

TABLE 62 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)

TABLE 63 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET, 2019-2028 (USD MILLION)

TABLE 64 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PARENTERAL BY REGION, 2019-2028 (USD MILLION)

TABLE 65 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GASTRO BY REGION, 2019-2028 (USD MILLION)

TABLE 66 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, ENT BY REGION, 2019-2028 (USD MILLION)

TABLE 67 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)

TABLE 69 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY REGION, 2018-2027 (MILLION UNITS)

TABLE 70 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 71 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY COUNTRY ,2019-2028 (USD MILLION)

TABLE 72 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY COUNTRY ,2019-2028 (MILLION UNITS)

TABLE 73 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 74 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)

TABLE 75 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)

TABLE 76 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)

TABLE 77 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 78 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)

TABLE 79 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)

TABLE 80 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)

TABLE 81 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)

TABLE 82 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)

TABLE 83 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)

TABLE 84 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)

TABLE 85 NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)

TABLE 86 NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)

TABLE 87 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)

TABLE 88 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)

TABLE 89 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)

TABLE 90 U.S. PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 91 U.S. PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)

TABLE 92 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)

TABLE 93 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)

TABLE 94 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 95 U.S. PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)

TABLE 96 U.S. PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)

TABLE 97 U.S. PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)

TABLE 98 U.S. PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)

TABLE 99 U.S. PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)

TABLE 100 U.S. PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)

TABLE 101 U.S. PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)

TABLE 102 U.S. PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)

TABLE 103 U.S. PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)

TABLE 104 U.S. PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)

TABLE 105 U.S. PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)

TABLE 106 U.S. PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)

TABLE 107 CANADA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 108 CANADA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)

TABLE 109 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)

TABLE 110 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)

TABLE 111 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 112 CANADA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)

TABLE 113 CANADA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)

TABLE 114 CANADA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)

TABLE 115 CANADA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)

TABLE 116 CANADA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)

TABLE 117 CANADA PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)

TABLE 118 CANADA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)

TABLE 119 CANADA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)

TABLE 120 CANADA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)

TABLE 121 CANADA PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)

TABLE 122 CANADA PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)

TABLE 123 CANADA PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)

TABLE 124 MEXICO PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 125 MEXICO PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)

TABLE 126 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)

TABLE 127 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)

TABLE 128 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 129 MEXICO PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)

TABLE 130 MEXICO PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)

TABLE 131 MEXICO PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)

TABLE 132 MEXICO PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)

TABLE 133 MEXICO PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)

TABLE 134 MEXICO PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)

TABLE 135 MEXICO PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)

TABLE 136 MEXICO PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)

TABLE 137 MEXICO PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)

TABLE 138 MEXICO PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)

TABLE 139 MEXICO PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)

TABLE 140 MEXICO PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)

 

List of Figure

LIST OF FIGURES 

FIGURE 1 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: THE DRUG TYPE LIFE LINE CURVE

FIGURE 7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: THE MARKET CHALLENGE MATRIX

FIGURE 11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SEGMENTATION

FIGURE 12 GROWING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING IS DRIVING THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 GLASS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN 2021 & 2028

FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR PHARMACEUTICAL VIALS MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL VIALS MARKET

FIGURE 16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL, 2020

FIGURE 17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY NECK TYPE, 2020

FIGURE 18 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY CAP SIZE, 2020

FIGURE 19 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 20 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY CAPACITY, 2020

FIGURE 21 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY DRUG TYPE, 2020

FIGURE 22 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY APPLICATION, 2020

FIGURE 23 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY END-USER, 2020

FIGURE 24 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MARKET, 2020

FIGURE 25 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SNAPSHOT (2019)

FIGURE 26 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2019)

FIGURE 27 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2020 & 2027)

FIGURE 28 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2019 & 2027)

FIGURE 29 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL (2020-2027)

FIGURE 30 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SNAPSHOT (2020)

FIGURE 31 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2020)

FIGURE 32 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 33 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 34 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL (2021-2028)

FIGURE 35 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY SHARE 2020 (%)

 

View Infographics

LIST OF FIGURES 

FIGURE 1 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: THE DRUG TYPE LIFE LINE CURVE

FIGURE 7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: THE MARKET CHALLENGE MATRIX

FIGURE 11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SEGMENTATION

FIGURE 12 GROWING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING IS DRIVING THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 GLASS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN 2021 & 2028

FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR PHARMACEUTICAL VIALS MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL VIALS MARKET

FIGURE 16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL, 2020

FIGURE 17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY NECK TYPE, 2020

FIGURE 18 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY CAP SIZE, 2020

FIGURE 19 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 20 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY CAPACITY, 2020

FIGURE 21 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY DRUG TYPE, 2020

FIGURE 22 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY APPLICATION, 2020

FIGURE 23 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY END-USER, 2020

FIGURE 24 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MARKET, 2020

FIGURE 25 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SNAPSHOT (2019)

FIGURE 26 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2019)

FIGURE 27 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2020 & 2027)

FIGURE 28 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2019 & 2027)

FIGURE 29 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL (2020-2027)

FIGURE 30 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SNAPSHOT (2020)

FIGURE 31 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2020)

FIGURE 32 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 33 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 34 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL (2021-2028)

FIGURE 35 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY SHARE 2020 (%)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 8500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19